Kiniksa Pharmaceuticals Ltd (NASDAQ:KNSA)
| 15.70 Delayed Data As of 3:59pm ET |  -0.13 / -0.82%Today’s Change | 10.29 Today|||52-Week Range 20.65 | +4.81% Year-to-Date |
Latest KNSA News | Press Releases
| Kiniksa Pharmaceuticals (KNSA) Up 14.7% YTD: Here's How Nov 24 / Zacks.com - Paid Partner Content | Wall Street Analysts See a 70.27% Upside in Kiniksa Pharmaceuticals, Ltd. (KNSA): Can the Stock Really Move This High? Nov 20 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 15.83 |
| Today’s open | 15.75 |
| Day’s range | 15.53 - 15.84 |
| Volume | 3,916 |
| Average volume (3 months) | 441,166 |
| Market cap | $1.1B |
Data as of 3:59pm ET, 11/28/2023
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -120.22% |
| Earnings growth (next 5 years) | -60.33% |
| Revenue growth (last year) | +471.24% |
| P/E ratio | NM |
| Price/Sales | 4.79 |
| Price/Book | 2.81 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VRNAVerona Pharma PLC | -0.42 | -3.03% |
| ---- | ||
| SAGESAGE Therapeutics In... | +0.18 | +0.94% |
| SNDXSyndax Pharmaceutica... | +0.19 | +1.23% |
Data as of 3:59pm ET, 11/28/2023
Financials
| Next reporting date | February 28, 2024 |
| EPS forecast (this quarter) | -$0.11 |
| Annual revenue (last year) | $220.2M |
| Annual profit (last year) | $183.4M |
| Net profit margin | 83.28% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Lexington, Massachusetts |
Forecasts
